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Hematopoietic stem cells (HSCs) are self-renewing
bone marrow cells that give rise to all blood lineages
and retain a remarkable capacity to proliferate in re-
sponse to insult. Although some controls on HSC ac-
tivation are known, little is understood about how this
process is linked to natural signals. We report that
the interferon-inducible GTPase Lrg-47 (Irgm1), pre-
viously shown to play a critical role in host defense,
inhibits baseline HSC proliferation and is required
for a normal HSC response to chemical and infec-
tious stimuli. Overproliferating Lrg-47/ HSCs are
severely impaired in functional repopulation assays,
and when challenged with hematopoietic ablation
by 5-fluorouracil or infection with Mycobacterium
avium, Lrg-47/ mice fail to achieve the expected
expansion response in stem and progenitor cell pop-
ulations. Our results establish a link between the
response to infection and HSC activation and dem-
onstrate a novel function for a member of the p47
GTPase family.
INTRODUCTION
Hematopoietic stem cells (HSCs) are largely quiescent, self-
renewing cells that give rise to all adult blood lineages. They
have a remarkable capacity to respond to proliferative stimuli
from a variety of insults, exiting their quiescent phase and under-
going a period of self-renewal and differentiation in order to
restore hematopoietic homeostasis. These cells possess enor-
mous therapeutic potential, which is currently limited by our
inability to direct ex vivo what HSCs achieve so easily in vivo—
self-renewal events leading to the expansion of HSC number.
In vivo HSC proliferation can be induced by several well-char-
acterized experimental methods (e.g., chemotherapeutic treat-
ment or bone marrow transplantation); however, previousattempts to elucidate the genetic and molecular controls on
this process have largely ignored the question of how the regu-
lation of HSC function might be linked to natural signals—such
as those emanating from the interplay between infectious agents
and the host immune system. Recently, this connection has
been indicated by results implicating Toll-like receptors as
directing stem and progenitor fates in vitro (Nagai et al., 2006);
however, a genetic link between immune system signaling and
in vivo HSC function has remained elusive.
In a previous study of the dynamics of gene expression
changes during a cycle of HSC activation (defined as induced
expansion and eventual return to quiescence; Venezia et al.,
2004), we identified genes involved in proliferative versus quies-
cent HSC functions. Interestingly, one family of genes identified
by this approach encodes the p47 GTPases (MacMicking, 2004;
Taylor et al., 2004), which have been recently redesignated as
immunity-related GTPases (IRG). Characterized as interferon
(IFN)-responsive effectors of the immune system, these genes
are maximally expressed in HSCs within 1 day after exposure
to 5-fluorouracil (5FU) and have been identified by other groups
in stem cell gene expression profiles (Ivanova et al., 2002; Ram-
alho-Santos et al., 2002).
In the past, the p47 GTPases have been characterized solely in
the context of the immune system. Indeed, one of these family
members, Lrg-47 (Sorace et al., 1995; also Ifi1, Irgm1) has
been shown to be required for host defense against a broad
range of intracellular pathogens, including Listeria, Toxoplasma,
Mycobacteria, and Trypanosoma cruzi (Collazo et al., 2001; Feng
et al., 2004; MacMicking et al., 2003; Santiago et al., 2005). In
previous in vitro studies, the host resistance defects of Lrg-47-
deficient mice have been associated with impaired intracellular
microbial killing, phagosome maturation, and autophagy
(Butcher et al., 2005; MacMicking et al., 2003; Martens et al.,
2004). Interestingly, recent work shows that the human ortholog
IRGM serves a similar immune role (Singh et al., 2006), and fur-
ther, a single-nucleotide polymorphism in this gene has been
shown to be correlated with Crohn’s disease (Wellcome Trust
Case Control Consortium, 2007; Parkes et al., 2007). In charac-
terizing the response of Lrg-47/ mice to several of theseCell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc. 83
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control what is normally a nonlethal infection but also develop
a profound pancytopenia prior to death (Feng et al., 2004; San-
tiago et al., 2005). This unexpected intersection of findings—
upregulation of Lrg-47 in HSCs in response to chemotherapeutic
stress, coupled with a major hematopoietic defect in Lrg-47/
mice confronted with infectious challenge—led us to test a novel
hypothesis, that Lrg-47 may regulate HSC function in the face of
either chemical or pathogenic stress.
RESULTS
We first examined the ability of Lrg-47/ mice to respond to
noninfectious stresses on the hematopoietic system, and we
chose two different modalities to address this question. When
exposed to a sublethal dose of irradiation, Lrg-47 knockout
(KO) mice showed impaired recovery of bone marrow and thymic
cellularity (Figure 1A), as well as impaired B lymphopoiesis
(Figure 1B). After 5FU treatment, Lrg-47/ mice, although ulti-
mately able to reestablish their baseline blood counts, exhibited
substantially delayed hematopoietic recovery (Figure 1C).
Together with the previous findings discussed above, these
results suggest a defect at the level of the HSC in mice lacking
the Lrg-47 gene.
To examine the functional properties of Lrg-47/ HSCs, we
performed competitive and noncompetitive bone marrow trans-
plantation assays with whole bone marrow obtained from KO an-
imals (Figure 2). In competitive repopulation assays, a constant
number (250,000) of wild-type (WT) competitor cells was ad-
mixed with varying amounts of Lrg-47/ whole bone marrow.
Engraftment analysis by peripheral blood chimerism (CD45.2
versus CD45.1) at successive 4 week time points posttransplant
showed a profound deficit in KO marrow, as peripheral blood el-
ements derived from Lrg-47/ HSCs were progressively lost in
favor of WT cells. Given a 2:1 advantage over the competitor
cells, Lrg-47/ marrow achieved on average only 3% engraft-
ment by 4 weeks posttransplant (a 12-fold deficit compared to
WT), with progressive deterioration of engraftment thereafter
(Figure 2A). More strikingly, a separate experiment showed
that even a 25:1 advantage to the KO marrow failed to produce
robust engraftment from Lrg-47/ HSCs (Figure 2B). Interest-
ingly, competitive repopulation assays performed with mice de-
ficient for Igtp (another member of the p47 GTPase family, with
a similar immune phenotype to Lrg-47; Taylor et al., 2000) failed
to demonstrate an engraftment defect, showing that the require-
ment for engraftment is not a general property of this gene family
(Figure 2B).
Noncompetitive transplant assays (Figure 2C) were also per-
formed, with the intent of providing strong selective pressure
for Lrg-47-deficient HSCs. Transplantation of 2 3 105 WT bone
marrow cells is normally sufficient to rescue and fully repopulate
the hematopoietic system of all lethally irradiated recipients, yet
this dose of cells from KO donors failed to rescue any recipients
from lethal irradiation. Although a dose of 2 3 106 KO cells pro-
vided rescue, engraftment was once again poor, with Lrg-47/
HSCs ultimately outcompeted by residual host HSCs, indicative
of impaired self-renewal. Importantly, although Lrg-47/ HSCs
showed poor engraftment, those cells that did engraft satisfy
the traditional definition of stem cells—exhibiting multipotential-84 Cell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc.ity (Figure 2D) and self-renewal (as shown by ability to engraft
secondary hosts; Figure S1 available online). In addition to
peripheral blood analysis, some recipients from noncompetitive
experiments were sacrificed, and engraftment analysis in other
compartments (bone marrow, spleen, and hematopoietic pro-
genitors) revealed that the peripheral blood engraftment faithfully
mirrors engraftment throughout the hematopoietic system
(Figure S1). Additional experiments showed that Lrg-47/
transplantation defects are not attributable to defects in marrow
homing (Figures S2A and S2B). Finally, transplantation of WT
marrow into Lrg-47/ recipients demonstrated that this engraft-
ment defect is cell autonomous and also showed that KO
recipients were more easily ablated (Figure S2C)—a finding con-
sistent with the above results (Figures 1A and 1B).
Despite the striking defects seen in the engraftment ability of
Lrg-47/ HSCs, at baseline, KO mice are largely normal, with
no conspicuous defects in the absence of immune challenge.
We did observe subtle hematopoietic alterations at baseline—in-
cluding a trend toward reduction in the cellularity of bone marrow
and peripheral blood as well as a shift in the differential counts of
peripheral blood leukocytes (Figure S3). In light of this mild
hematopoietic phenotype, coupled with the severe functional
Figure 1. Lrg-47 Is Required for Hematopoietic Recovery from Insult
(A and B) After sublethal irradiation, Lrg-47/ mice show impaired recovery of
hematopoietic organ cellularity as well as reduced bone marrow and splenic B
lymphocyte populations. Wild-type (WT; n = 5) and Lrg-47/ (n = 5) mice were
subjected to sublethal irradiation and were analyzed after 4 weeks for thymus
and bone marrow cellularity (A) and percentage of spleen and bone marrow
B cells ([B]; B220+CD19+ cells were identified by flow cytometric analysis).
(C) Recovery of peripheral blood elements after 5FU treatment is impaired,
exemplified here by absolute granulocyte counts. The peripheral blood of
mock-treated WT (n = 5), 5FU-treated WT (n = 9), and 5FU-treated Lrg-47/
(n = 9) mice was analyzed periodically over a 24 day period; pooled data
from two experiments with identical results are expressed as relative change
from cohort baseline (absolute granulocyte counts were indexed to naive
values for each group). Differences between treated WT and KO are statisti-
cally significant at 14 days after injection, with p = 0.009.
Error bars represent the SEM.
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Lrg-47 Links Host Defense and HSC ProliferationFigure 2. Lrg-47/ HSCs Show Marked Functional Defects in Bone Marrow Transplantation Assays
(A and B) Competitive bone marrow transplants. Whole bone marrow was isolated from CD45.2 WT or Lrg-47/ donors (A and B) as well as Igtp/ donors (B)
and admixed in varying ratios with a constant number (2.5 3 105) of whole bone marrow competitor cells from CD45.1 WT mice prior to injection into lethally
irradiated recipient mice (CD45.1; n = 7 recipients at the outset of the experiment). Engraftment was monitored by flow cytometric analysis of peripheral blood
chimerism at the indicated time points.
(C and D) Noncompetitive transplants. Whole bone marrow from CD45.2 WT or Lrg-47/ donors was transplanted without competitor into lethally irradiated
CD45.1 recipients (n = 5) at a dose of 2 3 105 or 2 3 106 cells, with peripheral blood chimerism monitored as before. Recipients receiving 2 3 105 KO cells
died within two weeks of transplant (*).
(D) Representative FACS profile of Lrg-47/ engraftment, shown with myeloid and lymphoid lineage markers. Despite strikingly poor engraftment, analysis of
Lrg-47/ HSC-derived peripheral blood at 16 weeks posttransplant demonstrates that these cells possess multilineage potential.
Error bars represent the SEM.defect revealed by transplantation challenge, we examined the
frequency distribution of HSCs, using the side population (SP)
method for Hoechst dye efflux (Camargo et al., 2006; Goodell
et al., 1996), and found that, although the KO animals demon-
strated a reduction in the relative abundance of long-term
HSCs in the bone marrow, this result was not statistically signif-
icant in repeated experiments (data not shown); the percentage
of the Sca1+, kit+, Lin (KSL) stem and progenitor cells was
comparable to that in WT mice. Thus, although Lrg-47/ mice
exhibit a slight reduction in HSC number, this cannot account
for the severe functional defects described above.
The delayed recovery of Lrg-47/ mice from 5FU treatment
suggested a possible proliferation defect in KO HSCs. To testthis idea, we assessed the proliferative status of Lrg-47/
HSCs by using 5-bromodeoxyuridine (BrdU) incorporation. After
a 3 day or 6 day in vivo exposure to BrdU (Hock et al., 2004),
HSCs (Sca1+ SP cells) from WT and KO animals were isolated,
and BrdU incorporation was analyzed by flow cytometry
(Figure 3A). Surprisingly, after 3 days of labeling, 20% of the
WT HSCs had incorporated BrdU, while the KO HSCs were sub-
stantially more proliferative (up to 65% BrdU positivity). This
relationship persisted over a 6 day BrdU exposure (Figure 3B).
In order to examine this phenomenon in the most primitive
HSC compartment, further work took advantage of the fact
that SPlow cells have the highest level of LT-HSC activity within
the SP (Camargo et al., 2006; Goodell et al., 1997); analysis ofCell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc. 85
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phenotypically defined KO long-term HSC compartment (LT-
HSC; Figure 3C).
These findings show that, in the absence of Lrg-47, HSCs are
hyperproliferative, implicating Lrg-47 as a key regulator of HSC
quiescence, even under homeostatic conditions. Previous stud-
ies have shown that actively cycling HSCs engraft poorly (Pas-
segue et al., 2005), consistent with the transplant data presented
in Figure 2. Yet, even once engrafted, recipients of Lrg-47/
HSCs show progressive loss of chimerism over time, indicating
a broader functional deficit than engraftment ability alone.
We next hypothesized that, lacking strict control over HSC
proliferation, Lrg-47 KO mice might be impaired in their re-
sponse to stress at the HSC level. Thus, we next sought to
examine the response of Lrg-47/ HSCs to proliferative stimuli,
using both chemotherapeutic and infectious challenges. Be-
cause 5FU consistently induces expansion of the HSC compart-
ment (Harrison and Lerner, 1991; Randall and Weissman, 1997;
Van Zant, 1984), causing the stem cells to enter cycle and pro-
liferate (an activity that peaks on day 6 posttreatment), we
treated WT and KO mice with this agent and then studied the
SP compartment at several time points thereafter. As expected,
Figure 3. Lrg-47 Negatively Regulates HSC Proliferation in the
Steady State
HSC proliferation status was assessed by in vivo BrdU labeling. Sca-1+ SP
cells were purified from WT and Lrg-47/ mice after 3 or 6 days of BrdU ex-
posure. The sorting strategy and percentage of Sca-1+ cells in the entire SP
are illustrated in (A). After sorting, cells were permeabilized and stained for
BrdU incorporation, prior to reanalysis by flow cytometry. Upon reflow (B),
cells were identified as Sca1+, and percentage of Sca-1+ SP cells that incor-
porated BrdU over the labeling period is indicated. In (C), WT and Lrg-47/
marrow was fractionated on the basis of SPlow (most primitive LT-HSC) versus
SPhigh gating, in addition to Sca-1 positivity, and analyzed as in (B). Data are
representative of three independent experiments utilizing pools of bone mar-
row from three to four WT and Lrg-47/ mice in each.86 Cell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc.WT mice show a marked increase in HSCs at 6 days posttreat-
ment, whereas Lrg-47/ mice showed a drastically impaired
expansion of this compartment, on both a relative and absolute
basis (Figures 4A and 4B). Analysis at later time points reveals
that Lrg-47/ mice are able to muster a subdued LT-HSC ex-
pansion, albeit a delayed one. Interestingly, observation at day 1
posttreatment reveals that, in contrast to the slight losses of
HSCs sustained by WT mice (35% of absolute HSC number),
Lrg-47/ KOs had severe stem cell losses within 24 hr after 5FU
administration (75%)—a result that agrees with their increased
proliferative status and consequent enhanced susceptibility to
5FU, a chemotherapeutic agent that kills cycling cells. Analysis
of the KSL compartment of KO animals revealed that caspase
activity is increased at roughly twice the normal levels after in
vitro treatment with 5FU (Figure S4), suggesting that the vulner-
ability to 5FU may be mediated at least in part through apoptotic
pathways.
Previous observations of pancytopenia in pathogen-infected
Lrg-47/ mice suggested that this gene might link HSC regula-
tion to the normal immune response—so that infectious stimuli,
rather than nucleotide analogs, would provide the impetus for
a program of HSC activation. Thus, we investigated the response
of WT and Lrg-47/ stem and progenitor cells 4 weeks after
infection with M. avium. Importantly, we detected a striking
(15-fold) expansion of the WT KSL compartment in response
to this bacterial agent, with a notable lack of expansion in the
KO animals (Figure 4C) together with reduced marrow cellularity.
A similar result was obtained with CD150 (Kiel et al., 2005) as
a marker for stem cells (Figure S5). In vitro colony-forming
assays provide functional confirmation of this result (Figure 4D),
as whole bone marrow progenitor activity increases after
M. avium infection in WT, but not KO, animals. These results
strongly implicate the stem/progenitor cell populations as play-
ing a role in host resistance—Lrg-47/ mice succumb to infec-
tion after failure to maintain normal hematopoiesis—and demon-
strate at a genetic level that the immune response to infection is
a regulator of stem and progenitor function in vivo.
DISCUSSION
The data presented here implicate Lrg-47 as an important regu-
lator of HSC proliferation under both steady-state and stress
conditions. More broadly, consistent with recent results impli-
cating Toll-like receptors as directing stem and progenitor fates
in vitro (Nagai et al., 2006), this work establishes a link between
immune system signaling and in vivo HSC function, a relationship
that has largely proved elusive. How might Lrg-47 function ben-
efit the HSC compartment? Previous work has shown that, even
in steady-state conditions, control of HSC proliferation is tied to
functional integrity (Hock et al., 2004; Passegue et al., 2005).
Further, we know that, in the face of stress, strict control of
HSC proliferation is needed, as many stimuli that induce HSC
proliferation are themselves often cytotoxic. Although HSCs
must proliferate and expand when called upon, they must first
survive the toxicity associated with these insults. Our previous
expression profiling of 5FU-activated HSCs revealed that
Lrg-47 is maximally upregulated in the first 24 hr after insult, and
as shown here, its function is crucial to adequate HSC protec-
tion. Our findings thus point to a dual role for Lrg-47—first as
Cell Stem Cell
Lrg-47 Links Host Defense and HSC ProliferationFigure 4. Lrg-47/ HSCs Are Impaired in Their Response to Both Chemotherapeutic and Microbial Stress
(A) The frequency of HSCs (SP cells) in WT and Lrg-47/ mice was determined in both naive animals and mice that had been treated with 5FU 1, 6, 10, or 26 days
prior to analysis. The frequency of SP cells (gate) is indicated as a percentage of live cells.
(B) By multiplying the observed frequency of HSCs by the overall bone marrow cellularity, it is possible to discern changes in the absolute number of HSCs after
5FU treatment, reported here as absolute SP# / hindlimb; after 5FU treatment, KO mice exhibit severe ablation of the HSC compartment. Data in (A) and (B) are
representative of multiple experiments and were obtained from marrow pools of two to three mice per data point.
(C) WT and KO animals were infected intravenously with M. avium and sacrificed at 4 weeks postinfection. The percentage of the KSL population is indicated on
Lin gated plots.
(D) Four weeks after infection, whole bone marrow from WT and KO animals was plated in methylcellulose, and colony formation was assessed 12 days later.
Infection induced a statistically significant increase in progenitor activity in WT marrow (p = 0.0125 at 5k; p = 0.0003 at 10k). Infection actually induced a drop in KO
colony-forming activity (p = 0.0231 at 5k; p = 0.0940 at 10k). Data are representative of two experiments with identical results.
Error bars represent the SEM.an inhibitor of HSC proliferation at baseline, and second as an
induced player in the response to injury.
Yet, remarkably little is known about how the p47 GTPases
exert their effects. One possible model derives from the observa-
tion that IIGP (a p47 GTPase) interacts with hook3 (Kaiser et al.,
2004; a microtubule associated protein), suggesting that p47
GTPases may regulate cytoskeletal changes and/or cell motility.
This is an attractive hypothesis from a stem cell perspective, be-
cause the proliferative status of HSCs has been shown to be
linked to physical location within the endosteal microenviron-
ment (Wilson et al., 2004). Our data also suggest that Lrg-47
may play a role in pathways regulating cell death. Detailed inter-
actions of Lrg-47 in this system remain an open area of study thatmay illuminate heretofore unknown mechanisms regulating HSC
proliferation and fate decisions.
Interestingly, Lrg-47 has been heretofore known chiefly as an
effector of IFNg signaling—a pathway that has previously been
tied to hematopoiesis, as IFNg contributes to the pathogenesis
of Fanconi’s (Haneline et al., 1998; Whitney et al., 1996) and
aplastic anemias (Dufour et al., 2001; Nistico and Young,
1994), and has been shown in vitro to exert potent inhibitory
effects on hematopoiesis (Selleri et al., 1996). Additionally,
when subjected to infectious challenge, IFNg KO mice display
dysregulated expansion of certain hematopoietic progenitors
(Murray et al., 1998). Because Lrg-47 expression is strongly up-
regulated by IFNg, it is possible that these effects are mediatedCell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc. 87
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In addition, the previous observation that Lrg-47 is upregulated
in LPS-stimulated macrophages (Sorace et al., 1995) implicates
the TLR signaling pathway as a possible contributor to the Lrg-
47-dependent effects of infection on HSC activity. Future studies
will examine the requirement for IFN as well as TLR signaling for
Lrg-47 function in HSCs.
The cellular response to infection requires replenishment of
hematopoietically derived effector populations and conse-
quently provides proliferative stress on bone marrow progeni-
tors. The data presented here demonstrate that a gene previ-
ously shown to regulate host resistance to pathogens also
operates at the level of the HSC response and thereby identifies
a possible step in its host protective function. More generally, our
findings reveal an unexpected intersection point between the
fields of stem cell biology and the immune response to patho-
gens and suggest that defects in HSC function should be consid-
ered as possible determinants of host susceptibility to infection.
EXPERIMENTAL PROCEDURES
Mice
WT C57Bl/6 (CD45.2) and C57B1/6.SJL (CD45.1) were obtained from Taconic
Farms (Germantown, NY) or were bred at the animal care facility at the Baylor
College of Medicine (Houston, TX). Igtp/ and Lrg-47/ mice on a mixed
C57Bl/6J x 129 background were generated as described (Collazo et al.,
2001; Taylor et al., 2000) and were backcrossed ten times to C57Bl/6 mice.
KO mice on inbred B6 backgrounds were used for all transplant and infection
experiments. Due to poor breeding efficiency of fully backcrossed animals,
mice on mixed backgrounds (backcrossed thrice to B6) were used in the
5FU and BrdU experiments. After the mating of a single mixed background
KO male (129 backcrossed twice to C57Bl/6) with a fully inbred WT C57Bl/6
female, F2 progeny of this cross were used to established true breeding WT
and KO lines (backcrossed three times to C57Bl/6). From these lines, age
and gender-matched animals were used for all experiments, and key reported
results from mixed background experiments have been verified with inbred B6
mice. All mice were maintained at an AALAC-accredited, specific-pathogen-
free animal facility at the NIAID, NIH (Bethesda, MD) or the Baylor College
of Medicine (Houston, TX). Gender-matched mice of both sexes between
8 and 12 weeks of age were employed.
Flow Cytometry
MoFlo, LSRII, and FACS-Scan flow cytometers were used for analysis and
sorting. Whole bone marrow was stained with Hoechst 33342 for resolution
of the SP population as previously described (Goodell et al., 1996, 1997)
and magnetically enriched for Sca1+ cells (autoMACS; Miltenyi Biotec) when
appropriate for sorting. Staining for cell surface markers was performed as
previously described (Venezia et al., 2004)—briefly, lineage-negative cells
were identified by a lineage antibody cocktail (PharMingen or eBiosciences)
consisting of CD4, CD8, B220, GR1, CD11b, and Ter119. For KSL and
CD150 analysis, anti-c-kit, anti-Sca1, and anti-CD150 (BioLegend; TC15-
12F12.2) antibodies were used in conjunction with the lineage cocktail. For
experiments involving 5FU-treated animals, CD11b was excluded from the lin-
eage cocktail, as HSCs upregulate CD11b in response to 5FU (Randall and
Weissman, 1997).
Bone Marrow Transplantation
Noncompetitive bone marrow transplants were performed by retroorbital
intravenous injection of CD45.2 donor whole bone marrow cells from either
8- to 12-week-old Lrg-47/ mice or WT controls (C57Bl6) into CD45.1 WT
C57Bl6 recipients that had been lethally irradiated with a split dose of 10.5
Gy. For competitive transplants, dilutions of CD45.2 donor whole bone marrow
cells from WT and Lrg-47/ mouse strains were admixed with WT CD45.1
competitor prior to injection to CD45.1 recipients, as above.88 Cell Stem Cell 2, 83–89, January 2008 ª2008 Elsevier Inc.5FU Treatment and CBC Analysis
Mice were given intraperitoneal injections of 5FU (American Pharmaceutical
Partners) at 150 mg/kg in PBS. For CBCs, 63 ml of blood was collected by
retroorbital bleed and diluted 1:2 with CellDyn Diluent prior to analysis on
a CellDyn 3500.
Sublethal Irradiation and Mycobacterial Infection
Mice were exposed to 600 cGy of whole-body irradiation and tissue cellular-
ities examined 4 weeks thereafter. For mycobacterial infection, mice were
injected intravenously with 1 3 106 colony-forming units of M. avium (strain
SmT 2151) as previously described (Feng et al., 2004), and expansion of
KSL and CD150 populations was examined 4 weeks later.
BrdU Labeling
Mice received an initial intraperitoneal injection of BrdU (Sigma, 1 mg per 6 g of
mouse weight), followed by inclusion of BrdU in drinking water (Sigma, 1 mg/ml)
for either 3 (Hock et al., 2004) or 6 subsequent days. Mice were then sacrificed,
and Sca-1+ SP (or Sca-1+ SPlow versus SPhigh) cells were sorted into a carrier
population of 500,000 B220+ spleen cells. Samples were prepared for analysis
of BrdU incorporation by using the FITC BrdU Flow Kit (BD PharMingen), and
samples were reanalyzed by flow cytometry. Upon reanalysis, HSCs were
readily distinguishable from carrier cells, as Sca-1+ and B220, and analyzed
for BrdU incorporation.
Colony-Forming Assay
Whole bone marrow from naive and infected animals was plated in triplicate in
MethoCult GF M3434 (StemCell Technologies, Inc.) and incubated at 37C,
5% CO2. Colony formation was scored on the 12th day after plating.
Statistics
Student’s t test was used for statistical analyses, where appropriate. P values
are reported in the figure legends, and significance is indicated on the figures
using the following convention: *p < 0.05, **p < 0.01, and ***p < 0.001. Error
bars in all panels represent the SEM.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cellstemcell.
com/cgi/content/full/2/1/83/DC1/.
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